MedTrace Logo

Cost and Cost-effectiveness of PTB+ Treatment in Southern Ethiopia

NCT00913172 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 229

Last updated 2010-05-17

No results posted yet for this study

Summary

Evidences for policy making and decision related to the cost of delivering tuberculosis (TB) control is lacking in Ethiopia. The investigators aimed to determine the cost and cost-effectiveness of involving health extension workers (HEWs) in TB treatment under the community-based initiative in Ethiopia.

Conditions

  • Smear-positive TB Cases

Interventions

OTHER

Treatment

Directly observed treatment (DOT) by health extension workers (HEWs)

Sponsors & Collaborators

  • University of Bergen

    lead OTHER

Principal Investigators

  • Daniel G Datiko, MD · UoB, RHB

  • Bernt Lindtjorn, MD, PhD · UoB

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2007-03-31
Completion
2008-04-30

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913172 on ClinicalTrials.gov